2017
DOI: 10.1016/j.ejso.2017.04.003
|View full text |Cite
|
Sign up to set email alerts
|

The impact of perioperative fluid therapy on short-term outcomes and 5-year survival among patients undergoing colorectal cancer surgery – A prospective cohort study within an ERAS protocol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
46
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 65 publications
(53 citation statements)
references
References 26 publications
2
46
0
2
Order By: Relevance
“…The ERAS protocol, designed to reduce surgical stress, has in previous studies been shown to improve short-term postoperative recovery (morbidity/LOS) in Table 2 Overall pre-and intra-operative compliance to the Enhanced Recovery After Surgery (ERAS) protocol (12 items both open and laparoscopic colorectal surgery [16,17,[23][24][25][26]. Recently published data also suggest that the ERAS protocols may have positive effects on long-term outcome, as measured by 5-year survival [14,15]. The ERAS programme aims to standardize evidence-based perioperative interventions.…”
Section: Discussionmentioning
confidence: 99%
“…The ERAS protocol, designed to reduce surgical stress, has in previous studies been shown to improve short-term postoperative recovery (morbidity/LOS) in Table 2 Overall pre-and intra-operative compliance to the Enhanced Recovery After Surgery (ERAS) protocol (12 items both open and laparoscopic colorectal surgery [16,17,[23][24][25][26]. Recently published data also suggest that the ERAS protocols may have positive effects on long-term outcome, as measured by 5-year survival [14,15]. The ERAS programme aims to standardize evidence-based perioperative interventions.…”
Section: Discussionmentioning
confidence: 99%
“…Patients who had higher compliance (≥ 70%) to the protocol had reduced risk of 5-year cancer-specific death, HR 0.58 (95% CI 0.39–0.88). Restricted perioperative fluid therapy, one of the elements of ERAS protocol, has also been shown to be related to improved 5-year survival (cancer-specific death, HR 0.45, 95% CI 0.25–0.81) [ 69 ].…”
Section: Eras Impact On Long-term Outcomesmentioning
confidence: 99%
“…However, in a randomized trial, Puckett et al [7] concluded that targeting a lower urine output allowed administration of a smaller amount of intraoperative fluid without significant effects on clinical outcomes. Furthermore, the association of perioperative fluid overload with worsening of postoperative morbidity is well-established [8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%